PARP12-mediated ADP-ribosylation contributes to breast cancer cell fate by regulating AKT activation and DNA-damage response

蛋白激酶B PI3K/AKT/mTOR通路 癌症研究 DNA损伤 福克斯O1 转录因子 生物 程序性细胞死亡 DNA修复 细胞凋亡 细胞生物学 信号转导 生物化学 DNA 基因
作者
Anupama Pavithran,Maria Matarese,Barbara Morone,Angela Filograna,Matteo Lo Monte,Nina Alayne Dathan,Daniela Corda,Giovanna Grimaldi
出处
期刊:Cellular and Molecular Life Sciences [Springer Nature]
卷期号:82 (1): 58-58 被引量:5
标识
DOI:10.1007/s00018-025-05586-z
摘要

Breast cancer represents the primary cause of death of women under 65 in developed countries, due to the acquisition of multiple drug resistance mechanisms. The PI3K/AKT pathway is one of the major regulating mechanisms altered during the development of endocrine resistance and inhibition of steps in this signalling pathway are adopted as a key strategy to overcome this issue. ADP-ribosylation is a post-translational modification catalysed by PARP enzymes that regulates essential cellular processes, often altered in diseases. PARP12, a member of this family, has been associated with the onset of drug resistance in oestrogen receptor-positive breast cancers, making this enzyme a promising drug target. The molecular basis underlying its involvement in the acquisition of resistance are unknown to date. Here, we demonstrate that PARP12-mediated mono-ADP-ribosylation of AKT is required for AKT activation whilst the absence of PARP12 leads to apoptosis induction in a subset of oestrogen receptor-positive breast cancer cells. Our data show that transcriptional inhibition of PARP12 correlates with an increased DNA-damage induction, mirrored by augmented p53 nuclear localisation and enhanced p53-AKT interaction. Under these conditions, AKT is functionally incompetent towards its downstream targets FOXO, hence favouring cell death. This is achieved by increasing protein levels of the FOXO1 transcription factor, that in turn activates the apoptotic cascade. Overall, we show a novel regulation step of AKT activation and apoptosis relying on PARP12-mediated mono-ADP-ribosylation and propose PARP12 as a potential pharmacological target to be exploited as an innovative therapeutical strategy to overcome endocrine resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
薇子完成签到,获得积分10
1秒前
化工兔发布了新的文献求助10
1秒前
卿君完成签到,获得积分10
1秒前
1秒前
撇弃途上完成签到,获得积分10
2秒前
佳佳发布了新的文献求助10
2秒前
liqunzhang发布了新的文献求助10
2秒前
tyccc完成签到,获得积分10
3秒前
阿呆盘阿瓜完成签到,获得积分10
3秒前
3秒前
茂利完成签到,获得积分10
4秒前
文艺月亮完成签到,获得积分10
4秒前
Junt完成签到,获得积分10
5秒前
阮文名完成签到,获得积分10
5秒前
hy发布了新的文献求助10
5秒前
香蕉觅云的应助被wyzgood采纳,获得10
6秒前
啦啦完成签到,获得积分10
6秒前
SheepOne完成签到,获得积分10
6秒前
LSY完成签到,获得积分10
7秒前
阿飞发布了新的文献求助10
7秒前
7秒前
小黄人完成签到,获得积分10
7秒前
五五完成签到,获得积分10
8秒前
舒心易烟完成签到,获得积分10
8秒前
辛勤小蘑菇完成签到 ,获得积分10
8秒前
小斌发布了新的文献求助10
8秒前
LHP完成签到,获得积分0
8秒前
糟糕的修杰完成签到,获得积分10
8秒前
9秒前
商序廿三关注了科研通微信公众号
9秒前
孙畅完成签到 ,获得积分10
9秒前
9秒前
秋风卷落叶完成签到,获得积分10
9秒前
迷失的雄鹰54完成签到,获得积分20
10秒前
珂珂完成签到,获得积分10
10秒前
和平港湾完成签到,获得积分10
11秒前
幸福纸鹤完成签到,获得积分10
12秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173463
求助须知:如何正确求助?哪些是违规求助? 9565690
关于积分的说明 21781315
捐赠科研通 7767647
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476808